Results 1 to 10 of about 424,338 (262)

Gestational Choriocarcinoma [PDF]

open access: diamondInternational Journal of Gynecological Cancer, 2023
Gestational choriocarcinoma accounts for 5% of gestational trophoblastic neoplasms. Approximately 50%, 25%, and 25% of gestational choriocarcinoma occur after molar pregnancies, term pregnancies, and other gestational events, respectively.
María Isabel Silva Sánchez
semanticscholar   +7 more sources

Ultra-High-Risk Gestational Choriocarcinoma of the Ovary Associated with Ectopic Pregnancy [PDF]

open access: yesCurrent Oncology, 2023
Gestational choriocarcinoma of the ovary is an exceptionally rare and highly aggressive tumor. Preoperative diagnosis of extrauterine choriocarcinoma is difficult due to nonspecific clinical presentation and its resemblance to ectopic pregnancy.
Eva Pavla Malovrh   +4 more
doaj   +3 more sources

Gestational Choriocarcinoma [PDF]

open access: hybridDefinitions, 2020
A rare, highly malignant epithelial tumor that develops from a hydatidiform mole (50%), following abortion (25%), or during normal pregnancy (22%).
National Cancer Institute
semanticscholar   +5 more sources

Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma. [PDF]

open access: yesBiomedicines, 2021
The human placenta shares properties with solid tumors, such as rapid growth, tissue invasion, cell migration, angiogenesis, and immune evasion. However, the mechanisms that drive the evolution from premalignant proliferative placental diseases—called hydatidiform moles—to their malignant counterparts, gestational choriocarcinoma, as well as the ...
Collet C   +13 more
europepmc   +8 more sources

Pure primary non-gestational choriocarcinoma originating in the ovary: A case report and literature review. [PDF]

open access: goldRare Tumors, 2021
Non-gestational choriocarcinoma (NGCO) of the ovary is rare, with a prevalence of less than 0.6% of all ovarian germ-cell tumors; and when found with other germ cell tumors, pure NGCO is exceedingly rare.
Yu X, Du Q, Zhang X, Liu Y, Shen Y.
europepmc   +4 more sources

Cordycepin Inhibits Human Gestational Choriocarcinoma Cell Growth by Disrupting Centrosome Homeostasis. [PDF]

open access: greenDrug Des Devel Ther, 2020
Introduction Human gestational choriocarcinoma, a type of gestational trophoblastic disease, occurs after miscarriage, abortion, ectopic pregnancy, or molar pregnancy.
Wang CY   +6 more
europepmc   +4 more sources

A case of intraplacental gestational choriocarcinoma; characterised by the methylation pattern of the early placenta and an absence of driver mutations [PDF]

open access: yesBMC Cancer, 2019
Background Gestational choriocarcinoma is a rare malignancy believed to arise from the trophoblast cells of the placenta. Despite the frequently aggressive clinical nature, choriocarcinoma has been routinely curable with cytotoxic chemotherapy for over ...
Philip Savage   +9 more
doaj   +3 more sources

Ovarian ectopic pregnancy misdiagnosed as gestational choriocarcinoma: A case report. [PDF]

open access: diamondAnn Med Surg (Lond), 2022
Kazemi SN   +4 more
europepmc   +3 more sources

CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.

open access: yesDis Markers, 2022
Background Gestational choriocarcinoma (GC) is a rare malignant gestational trophoblastic tumor. Long noncoding RNA (lncRNA) CBR3 antisense RNA 1 (CBR3-AS1) has been reported to serve as a critical oncogene and facilitate tumor progression.
Zhang Y, Zhang H, Zhang X, Liu B.
europepmc   +2 more sources

Non-gestational Choriocarcinoma of the Ovary: A Report of a Rare Case From Saudi Arabia. [PDF]

open access: yesCureus
Non-gestational choriocarcinoma of the ovary is extremely rare and presents diagnostic and therapeutic challenges. Early recognition, appropriate surgical intervention, and adjuvant chemotherapy are essential for successful management.
Sait HK   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy